HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,392 | -45.2% | 5,519 | -47.9% | 0.00% | -50.0% |
| Q2 2023 | $902,399 | +18.3% | 10,599 | +9.3% | 0.00% | 0.0% |
| Q4 2022 | $762,512 | +388.8% | 9,695 | +358.6% | 0.00% | +300.0% |
| Q3 2022 | $156,000 | -44.1% | 2,114 | -52.2% | 0.00% | -50.0% |
| Q1 2022 | $279,000 | -0.7% | 4,420 | -16.6% | 0.00% | -33.3% |
| Q4 2021 | $281,000 | -24.1% | 5,299 | +1.2% | 0.00% | -40.0% |
| Q3 2021 | $370,000 | -23.1% | 5,236 | -27.4% | 0.01% | -28.6% |
| Q2 2021 | $481,000 | -20.1% | 7,212 | +32.9% | 0.01% | -30.0% |
| Q1 2021 | $602,000 | -9.9% | 5,425 | -3.6% | 0.01% | -23.1% |
| Q4 2020 | $668,000 | -37.2% | 5,629 | -53.8% | 0.01% | -43.5% |
| Q3 2020 | $1,063,000 | -46.3% | 12,182 | -29.2% | 0.02% | -74.2% |
| Q4 2019 | $1,978,000 | -16.7% | 17,218 | -8.6% | 0.09% | +67.9% |
| Q3 2019 | $2,375,000 | -2.7% | 18,831 | -7.2% | 0.05% | -11.7% |
| Q2 2019 | $2,442,000 | +15.0% | 20,293 | +9.5% | 0.06% | -25.0% |
| Q3 2018 | $2,123,000 | +43.3% | 18,532 | +12.2% | 0.08% | +19.4% |
| Q2 2018 | $1,481,000 | – | 16,510 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |